A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT03647124 · COMPLETED
Trial details
- NCT number
- NCT03647124
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-03-13
- Primary completion
- 2024-01-10
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.